SlideShare a Scribd company logo
TUTORIAL - TUMOR TYPE SEARCH

           Search for a cancer
           type of interest and
           discover the most
           significant altered
           genes and modules
STEP 1
Go to
www.intogen.org
& Click Browser
STEP 2
Select the tumor
type of your
interest
NOTE
                                       Cancer type annotations
                                       are based on International
                                       Classification of Disease
                                       (ICD)




ICD-10
nomenclature is
used to indicate
the topography or
site of the tumor
                    ICD-O
                    nomenclature is
                    used to indicate
                    the tumor
                    morphology or
                    subtype.
STEP 3
In this case we will select
breast cancer, and we will
leave blank the
morphology type.
We are in the page for all
                        experiments of Breast
                        Cancer, and all
                        genes/modules
                                 This table summarizes
                                 the evidence for the
                                 involvement of each
                                 gene in breast cancer




Note that you can
get the data in table
format by clicking on
‘CSV file’ under
‘Export”
This part gives summary
                                                           information of the
                                                           alterations found in each
                                                           gene in the cancer type
                                                           selected given a number
                                                           of experiments
                                                           combined




                                                              These colors indicate
                                                              significance. Colors
                                                              toward red means
                                                              that this gene is
                                                              significantly altered
                                                              in this tumor type




Color scale of corrected p-
values:
Gray = no significantly
altered
Red/Yellow = significantly
altered
                              Gray means that this    White means that
                              gene is not             there is no data for
                              significantly altered   this gene in this
                              in this tumor type.     tumor type
These values are based
on predictions by CGPrio
method. Genes with
higher probability rank are
more likely to be involved
in cancer.
See Furney et al., NAR
2008
STEP 4
You can sort the table by
clicking to the title of any
column. For example click
Down.
Now the genes in the                  Note that some
top are those                         genes are both
significantly                         significantly lost and
downregulated in                      downregulated.
breast cancer.




                       With these links you
                       can navigate to the
                       next pages to see the
                       rest of the genes
STEP 5
Now we will sort the
table to find the
genes with more
mutations known in
breast cancer
The first number is the number of
                                            samples with mutations in this
                     Now the genes in the   gene, and the second number is
                     top are those with     the number of samples analyzed.
                     higher number of       This information is based on
                     mutations known in     COSMIC.
                     breast cancer.




We are browsing the
information for genes in
Breast cancer. But we
can also browse other
information.




This column informs whether
the gene is in the Cancer
Gene Census of the Sanger
Center and which type of
mutations are known in
cancer samples.
STEP 6
Select GO process from
Modules tab to
discover the most
altered biological
processes in breast
cancer.
This table gives
information on altered
GO processes in breast
cancer.
STEP 7
                         If we click to the Up title, we will
                         sort by the pathways that have
                         the highest enrichment of genes
                         up-regulated in breast cancer.




                                 Here, the red color
                                 indicates that the
                                 module (GO process) is
                                 enriched for altered
                                 (up-regulated) genes in
Gray means that the              breast cancer.
number of genes in
this pathway that are
altered are not higher
than expected by
chance
STEP 8
Click on the Genes Tab
to go back to the genes
table
STEP 9
You can also search
for a gene of your
interest to see how it
is altered in breast
cancer. For example
type CDKN2A and
click search.
STEP 10
Click on the Ensembl ID for
the CDKN2A gene.
Note that now we are
                                                          in the page of
                                                          CDKN2A for breast
                                                          cancer




             STEP 11
       Click on Tumor types
       Tab




                                                           This box shows details of
This box shows the p-                                      mutations of CDKN2A in
value for up-regulation                                    breast cancer: The
and down-regulation of                                     number of samples with
                              This box shows details of
CDKN2A in breast                                           mutations (46), the
                              the annotations of this
cancer.                                                    number of samples
                              gene in the Cancer Gene
                                                           analyzed (1003) and the
                              Census of the Sanger
                                                           link to COSMIC for this
                              Center.
                                                           gene.
STEP 12
             Now click on
             Experiments Tab




This table provides
information on the
alterations found in
CDKN2A in different
morphology types for
Breast Cancer.
This is the list of experiments                       STEP 13
that have analyzed CDKN2A                        Click Down to sort the
in breast cancer.                                table for those
                                                 experiments in which
                                                 this gene is more
                                                 significantly down-
                                                 regulated.




                                                                    N = number
                                    White cells means no
                                                                    of samples
                                    data. In this case              analyzed
                                    means that this
                                    experiment has not
                                    analyzed for
                                    transcriptomic
                                    alterations


                                  Coloured cells indicate
                                  that this gene is down-
                                  regulated in a
                                  significant number of
                                  samples of the
     STEP 14                      experiment.
Click on Yu K et al to
see the details of the
experiment.
Note that now we are
                                                                      in the page of
                                                                      CDKN2A for a
                                                                      particular experiment
                                                                      of breast cancer

                               STEP 15
                           To see what is the involvement of
                           CDKN2A in other cancer types click “all”
                           in experiments and “all” in tumor types.




                                                              This box gives details of
This box shows details                                        down-regulation of
of the experiment,                                            CDKN2A in this
including authors, title                                      experiment. 183 samples
and link to the                                               have been analyzed, of
publication or original                                       which 24 have this gene
source of data.                                               down-regulated. The
                                                              expected number of
                                                              samples with down-
                                                              regulation by chance is
                                                              about 8. This is highly
                                                              significant down-
                                                              regulation.
Note that now we are
                           in the page of
                           CDKN2A for all tumor
                           types




Go to
the tab
“tumor
type”.




    This table gives
    information of known
    cancer alterations
    found in CDKN2A
    gene
THANKS FOR USING INTOGEN

        You will find more
        tutorials and
        documentation in
        www.intogen.org

More Related Content

What's hot

Tumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asTumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asmds-web
 
Research Paper - Naushad Moti
Research Paper - Naushad MotiResearch Paper - Naushad Moti
Research Paper - Naushad MotiNaushad Moti
 
Fragile sites in the cancer
Fragile sites in the cancer Fragile sites in the cancer
Fragile sites in the cancer angelaac
 
Research Paper - Naushad Moti
Research Paper - Naushad MotiResearch Paper - Naushad Moti
Research Paper - Naushad MotiNaushad Moti
 
ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases
ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases
ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases European School of Oncology
 
Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...
Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...
Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...
ILRI
 
Analysis of primary breast tumour stromal cells and their potential role in d...
Analysis of primary breast tumour stromal cells and their potential role in d...Analysis of primary breast tumour stromal cells and their potential role in d...
Analysis of primary breast tumour stromal cells and their potential role in d...
Marion Hartmann
 
Evaluation of EVI1 and EVI1s (δ324) by Julian David Hincapie
Evaluation of EVI1 and EVI1s (δ324) by Julian David HincapieEvaluation of EVI1 and EVI1s (δ324) by Julian David Hincapie
Evaluation of EVI1 and EVI1s (δ324) by Julian David HincapieJulián Hincapié
 
Clinical drug therapy nursing capitulo onco
Clinical drug therapy nursing capitulo oncoClinical drug therapy nursing capitulo onco
Clinical drug therapy nursing capitulo oncoClinica de imagenes
 
Oncogenesis
OncogenesisOncogenesis
Oncogenesis
Mehakinder Singh
 
Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...
Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...
Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...Hannah Cho
 
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrated glioma
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrated gliomaNuclear FABP7 immunoreactivity is preferentially expressed in infiltrated glioma
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrated gliomaYu Liang
 

What's hot (14)

Tumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asTumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer as
 
Research Paper - Naushad Moti
Research Paper - Naushad MotiResearch Paper - Naushad Moti
Research Paper - Naushad Moti
 
Fragile sites in the cancer
Fragile sites in the cancer Fragile sites in the cancer
Fragile sites in the cancer
 
poster
posterposter
poster
 
Research Paper - Naushad Moti
Research Paper - Naushad MotiResearch Paper - Naushad Moti
Research Paper - Naushad Moti
 
CDD 2015
CDD 2015CDD 2015
CDD 2015
 
ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases
ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases
ABC1 - L. van't Veer - Genomic signatures of specific sites of metastases
 
Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...
Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...
Risk of exposure to Campylobacter through consumption of ready-to-eat roast b...
 
Analysis of primary breast tumour stromal cells and their potential role in d...
Analysis of primary breast tumour stromal cells and their potential role in d...Analysis of primary breast tumour stromal cells and their potential role in d...
Analysis of primary breast tumour stromal cells and their potential role in d...
 
Evaluation of EVI1 and EVI1s (δ324) by Julian David Hincapie
Evaluation of EVI1 and EVI1s (δ324) by Julian David HincapieEvaluation of EVI1 and EVI1s (δ324) by Julian David Hincapie
Evaluation of EVI1 and EVI1s (δ324) by Julian David Hincapie
 
Clinical drug therapy nursing capitulo onco
Clinical drug therapy nursing capitulo oncoClinical drug therapy nursing capitulo onco
Clinical drug therapy nursing capitulo onco
 
Oncogenesis
OncogenesisOncogenesis
Oncogenesis
 
Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...
Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...
Poster 2016 Investigating CXCL10 as the potential target of miR135a in breast...
 
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrated glioma
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrated gliomaNuclear FABP7 immunoreactivity is preferentially expressed in infiltrated glioma
Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrated glioma
 

Viewers also liked

i楼市
i楼市i楼市
i楼市
MobileSearch
 
Making the Most of Plug-ins - WordCamp Toronto 2008
Making the Most of Plug-ins - WordCamp Toronto 2008Making the Most of Plug-ins - WordCamp Toronto 2008
Making the Most of Plug-ins - WordCamp Toronto 2008
Brendan Sera-Shriar
 
82378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-182378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-1pipis397
 
La graviola
La graviolaLa graviola
La graviola
Liliana Neira
 
82378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-182378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-1
pipis397
 
Lectores estrellas de Primaria
Lectores estrellas de PrimariaLectores estrellas de Primaria
Lectores estrellas de PrimariaPaola Padilla
 
¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!
¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!
¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!pipis397
 
Opleiden in de School in Rotterdam
Opleiden in de School in RotterdamOpleiden in de School in Rotterdam
Opleiden in de School in Rotterdam
Luc Sluijsmans
 
Teamworks Campaign Blueprint
Teamworks Campaign BlueprintTeamworks Campaign Blueprint
Teamworks Campaign BlueprintJudy Lane
 
Curriculum specification F4
Curriculum specification F4Curriculum specification F4
Curriculum specification F4hajahrokiah
 
Resultaten project lerarentekort Rotterdam juni 2011
Resultaten project lerarentekort Rotterdam juni 2011Resultaten project lerarentekort Rotterdam juni 2011
Resultaten project lerarentekort Rotterdam juni 2011Luc Sluijsmans
 
Artikel opleiden in de school in Rotterdam
Artikel opleiden in de school in RotterdamArtikel opleiden in de school in Rotterdam
Artikel opleiden in de school in RotterdamLuc Sluijsmans
 
Sample data and other ur ls
Sample data and other ur lsSample data and other ur ls
Sample data and other ur lsMark Wilkinson
 
Virtual Event Planning
Virtual Event PlanningVirtual Event Planning
Virtual Event Planning
RayFerreira
 
Bambu Communication Group Credential
Bambu Communication Group CredentialBambu Communication Group Credential
Bambu Communication Group Credential
Лада Петухова
 
Building a community around your blog v3
Building a community around your blog v3Building a community around your blog v3
Building a community around your blog v3
Brendan Sera-Shriar
 

Viewers also liked (20)

i楼市
i楼市i楼市
i楼市
 
Making the Most of Plug-ins - WordCamp Toronto 2008
Making the Most of Plug-ins - WordCamp Toronto 2008Making the Most of Plug-ins - WordCamp Toronto 2008
Making the Most of Plug-ins - WordCamp Toronto 2008
 
82378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-182378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-1
 
La graviola
La graviolaLa graviola
La graviola
 
82378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-182378 andrea bocelli-y_celline_dion-1
82378 andrea bocelli-y_celline_dion-1
 
Lectores estrellas de Primaria
Lectores estrellas de PrimariaLectores estrellas de Primaria
Lectores estrellas de Primaria
 
¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!
¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!
¡LA INTERNACIONALIZACIÓN DE LA AMAZONA!
 
CDIS DR. FSM
CDIS    DR. FSMCDIS    DR. FSM
CDIS DR. FSM
 
Opleiden in de School in Rotterdam
Opleiden in de School in RotterdamOpleiden in de School in Rotterdam
Opleiden in de School in Rotterdam
 
Teamworks Campaign Blueprint
Teamworks Campaign BlueprintTeamworks Campaign Blueprint
Teamworks Campaign Blueprint
 
Curriculum specification F4
Curriculum specification F4Curriculum specification F4
Curriculum specification F4
 
Resultaten project lerarentekort Rotterdam juni 2011
Resultaten project lerarentekort Rotterdam juni 2011Resultaten project lerarentekort Rotterdam juni 2011
Resultaten project lerarentekort Rotterdam juni 2011
 
Artikel opleiden in de school in Rotterdam
Artikel opleiden in de school in RotterdamArtikel opleiden in de school in Rotterdam
Artikel opleiden in de school in Rotterdam
 
My staff
My staffMy staff
My staff
 
Tutorial 1.3 - Run Enrichment Analysis
Tutorial 1.3 - Run Enrichment AnalysisTutorial 1.3 - Run Enrichment Analysis
Tutorial 1.3 - Run Enrichment Analysis
 
Sample data and other ur ls
Sample data and other ur lsSample data and other ur ls
Sample data and other ur ls
 
Virtual Event Planning
Virtual Event PlanningVirtual Event Planning
Virtual Event Planning
 
Parade of books!
Parade of books!Parade of books!
Parade of books!
 
Bambu Communication Group Credential
Bambu Communication Group CredentialBambu Communication Group Credential
Bambu Communication Group Credential
 
Building a community around your blog v3
Building a community around your blog v3Building a community around your blog v3
Building a community around your blog v3
 

Similar to Tumor Type Search

Cancer evolution
Cancer evolutionCancer evolution
Cancer evolution
somaie mohammadpour
 
OncoGenomics Explorer
OncoGenomics ExplorerOncoGenomics Explorer
OncoGenomics Explorerhlodeniu
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
Robert J Miller MD
 
Comparitive genomic hybridisation
Comparitive genomic hybridisationComparitive genomic hybridisation
Comparitive genomic hybridisation
namrathrs87
 
OncoGenomics Explorer2
OncoGenomics Explorer2OncoGenomics Explorer2
OncoGenomics Explorer2hlodeniu
 
Clinical Assessment In Incorporating a Personal Genome
Clinical Assessment In Incorporating a Personal GenomeClinical Assessment In Incorporating a Personal Genome
Clinical Assessment In Incorporating a Personal Genome
Diego Herrera
 
Unfortunately several cancers are not predictable with simple tests .pdf
Unfortunately several cancers are not predictable with simple tests .pdfUnfortunately several cancers are not predictable with simple tests .pdf
Unfortunately several cancers are not predictable with simple tests .pdf
aquastore223
 
Rare events or not i want to know about them
Rare events or not i want to know about themRare events or not i want to know about them
Rare events or not i want to know about them
Mehis Pold
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
Joaquin Dopazo
 
Prognostic markers on Breast Cancer
Prognostic markers on Breast CancerPrognostic markers on Breast Cancer
Prognostic markers on Breast Cancer
abizarl
 
Molecular profiling of breast cancer
Molecular profiling of breast cancerMolecular profiling of breast cancer
Molecular profiling of breast cancer
Hriman Sharma Sarkar
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene finding
Joaquin Dopazo
 
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
inventionjournals
 
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
inventionjournals
 
Genomics Technologies
Genomics TechnologiesGenomics Technologies
Genomics Technologies
Sean Davis
 
Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.
Fran Supek
 

Similar to Tumor Type Search (20)

Combine Experiments
Combine ExperimentsCombine Experiments
Combine Experiments
 
Cancer evolution
Cancer evolutionCancer evolution
Cancer evolution
 
OncoGenomics Explorer
OncoGenomics ExplorerOncoGenomics Explorer
OncoGenomics Explorer
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
Comparitive genomic hybridisation
Comparitive genomic hybridisationComparitive genomic hybridisation
Comparitive genomic hybridisation
 
Translating next generation sequencing to practice
Translating next generation sequencing to practiceTranslating next generation sequencing to practice
Translating next generation sequencing to practice
 
Analyze Your Modules
Analyze Your ModulesAnalyze Your Modules
Analyze Your Modules
 
OncoGenomics Explorer2
OncoGenomics Explorer2OncoGenomics Explorer2
OncoGenomics Explorer2
 
Clinical Assessment In Incorporating a Personal Genome
Clinical Assessment In Incorporating a Personal GenomeClinical Assessment In Incorporating a Personal Genome
Clinical Assessment In Incorporating a Personal Genome
 
Unfortunately several cancers are not predictable with simple tests .pdf
Unfortunately several cancers are not predictable with simple tests .pdfUnfortunately several cancers are not predictable with simple tests .pdf
Unfortunately several cancers are not predictable with simple tests .pdf
 
Rare events or not i want to know about them
Rare events or not i want to know about themRare events or not i want to know about them
Rare events or not i want to know about them
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
 
Prognostic markers on Breast Cancer
Prognostic markers on Breast CancerPrognostic markers on Breast Cancer
Prognostic markers on Breast Cancer
 
Molecular profiling of breast cancer
Molecular profiling of breast cancerMolecular profiling of breast cancer
Molecular profiling of breast cancer
 
From reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene findingFrom reads to pathways for efficient disease gene finding
From reads to pathways for efficient disease gene finding
 
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
 
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
Cell-free DNA Levels Serum Patients with Benign and Malignant Epithelial Ovar...
 
Genomics Technologies
Genomics TechnologiesGenomics Technologies
Genomics Technologies
 
Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.Synonymous mutations as drivers in human cancer genomes.
Synonymous mutations as drivers in human cancer genomes.
 
Lehrach
LehrachLehrach
Lehrach
 

More from Biomedical Genomics (GRIB)

Tutorial 1.6 - Export heatmap image and table results
Tutorial 1.6 - Export heatmap image and table resultsTutorial 1.6 - Export heatmap image and table results
Tutorial 1.6 - Export heatmap image and table resultsBiomedical Genomics (GRIB)
 

More from Biomedical Genomics (GRIB) (6)

Tutorial 1.6 - Export heatmap image and table results
Tutorial 1.6 - Export heatmap image and table resultsTutorial 1.6 - Export heatmap image and table results
Tutorial 1.6 - Export heatmap image and table results
 
Tutorial 1.5 - Edit heatmaps
Tutorial 1.5 - Edit heatmapsTutorial 1.5 - Edit heatmaps
Tutorial 1.5 - Edit heatmaps
 
Tutorial 1.4 - Explore results in a heatmap
Tutorial 1.4 - Explore results in a heatmapTutorial 1.4 - Explore results in a heatmap
Tutorial 1.4 - Explore results in a heatmap
 
Tutorial 1.2 - Import modules from Biomart
Tutorial 1.2 - Import modules from BiomartTutorial 1.2 - Import modules from Biomart
Tutorial 1.2 - Import modules from Biomart
 
Tutorial 1.1 - Import Intogen tumor types
Tutorial 1.1 - Import Intogen tumor typesTutorial 1.1 - Import Intogen tumor types
Tutorial 1.1 - Import Intogen tumor types
 
Gitools
GitoolsGitools
Gitools
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 

Tumor Type Search

  • 1. TUTORIAL - TUMOR TYPE SEARCH Search for a cancer type of interest and discover the most significant altered genes and modules
  • 3. STEP 2 Select the tumor type of your interest
  • 4. NOTE Cancer type annotations are based on International Classification of Disease (ICD) ICD-10 nomenclature is used to indicate the topography or site of the tumor ICD-O nomenclature is used to indicate the tumor morphology or subtype.
  • 5. STEP 3 In this case we will select breast cancer, and we will leave blank the morphology type.
  • 6. We are in the page for all experiments of Breast Cancer, and all genes/modules This table summarizes the evidence for the involvement of each gene in breast cancer Note that you can get the data in table format by clicking on ‘CSV file’ under ‘Export”
  • 7. This part gives summary information of the alterations found in each gene in the cancer type selected given a number of experiments combined These colors indicate significance. Colors toward red means that this gene is significantly altered in this tumor type Color scale of corrected p- values: Gray = no significantly altered Red/Yellow = significantly altered Gray means that this White means that gene is not there is no data for significantly altered this gene in this in this tumor type. tumor type
  • 8. These values are based on predictions by CGPrio method. Genes with higher probability rank are more likely to be involved in cancer. See Furney et al., NAR 2008
  • 9. STEP 4 You can sort the table by clicking to the title of any column. For example click Down.
  • 10. Now the genes in the Note that some top are those genes are both significantly significantly lost and downregulated in downregulated. breast cancer. With these links you can navigate to the next pages to see the rest of the genes
  • 11. STEP 5 Now we will sort the table to find the genes with more mutations known in breast cancer
  • 12. The first number is the number of samples with mutations in this Now the genes in the gene, and the second number is top are those with the number of samples analyzed. higher number of This information is based on mutations known in COSMIC. breast cancer. We are browsing the information for genes in Breast cancer. But we can also browse other information. This column informs whether the gene is in the Cancer Gene Census of the Sanger Center and which type of mutations are known in cancer samples.
  • 13. STEP 6 Select GO process from Modules tab to discover the most altered biological processes in breast cancer.
  • 14. This table gives information on altered GO processes in breast cancer.
  • 15. STEP 7 If we click to the Up title, we will sort by the pathways that have the highest enrichment of genes up-regulated in breast cancer. Here, the red color indicates that the module (GO process) is enriched for altered (up-regulated) genes in Gray means that the breast cancer. number of genes in this pathway that are altered are not higher than expected by chance
  • 16. STEP 8 Click on the Genes Tab to go back to the genes table
  • 17. STEP 9 You can also search for a gene of your interest to see how it is altered in breast cancer. For example type CDKN2A and click search.
  • 18. STEP 10 Click on the Ensembl ID for the CDKN2A gene.
  • 19. Note that now we are in the page of CDKN2A for breast cancer STEP 11 Click on Tumor types Tab This box shows details of This box shows the p- mutations of CDKN2A in value for up-regulation breast cancer: The and down-regulation of number of samples with This box shows details of CDKN2A in breast mutations (46), the the annotations of this cancer. number of samples gene in the Cancer Gene analyzed (1003) and the Census of the Sanger link to COSMIC for this Center. gene.
  • 20. STEP 12 Now click on Experiments Tab This table provides information on the alterations found in CDKN2A in different morphology types for Breast Cancer.
  • 21. This is the list of experiments STEP 13 that have analyzed CDKN2A Click Down to sort the in breast cancer. table for those experiments in which this gene is more significantly down- regulated. N = number White cells means no of samples data. In this case analyzed means that this experiment has not analyzed for transcriptomic alterations Coloured cells indicate that this gene is down- regulated in a significant number of samples of the STEP 14 experiment. Click on Yu K et al to see the details of the experiment.
  • 22. Note that now we are in the page of CDKN2A for a particular experiment of breast cancer STEP 15 To see what is the involvement of CDKN2A in other cancer types click “all” in experiments and “all” in tumor types. This box gives details of This box shows details down-regulation of of the experiment, CDKN2A in this including authors, title experiment. 183 samples and link to the have been analyzed, of publication or original which 24 have this gene source of data. down-regulated. The expected number of samples with down- regulation by chance is about 8. This is highly significant down- regulation.
  • 23. Note that now we are in the page of CDKN2A for all tumor types Go to the tab “tumor type”. This table gives information of known cancer alterations found in CDKN2A gene
  • 24. THANKS FOR USING INTOGEN You will find more tutorials and documentation in www.intogen.org